In Vivo Fat Quantification: Monitoring Effects of a 6-Week Non-Energy-Restricted Ketogenic Diet in Healthy Adults Using MRI, ADP and BIA.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
17 Jan 2020
Historique:
received: 16 08 2019
revised: 23 12 2019
accepted: 08 01 2020
entrez: 23 1 2020
pubmed: 23 1 2020
medline: 20 11 2020
Statut: epublish

Résumé

The ketogenic diet (KD) is a very low-carbohydrate, high-fat, and adequate-protein diet that induces many metabolic adaptations when calorie intake is not limited. Its therapeutic use in a range of diseases including cancer is currently being investigated. Our objective was to firstly assess the impact of a 6-week non-energy-restricted KD on the abdominal fat distribution and the hepatic fat composition in healthy adults. Body fat distribution and composition were measured by comparing magnetic resonance imaging (MRI) and spectroscopy (MRS) results with air displacement plethysmography (ADP) and bioelectrical impedance analysis (BIA) measurements. A total of 12 subjects from the KetoPerformance study were recruited for this ancillary study. Body mass index (BMI), total mass, total fat mass, total subcutaneous mass, and subcutaneous fat mass decreased significantly. None of the MRS parameters showed a significant change during the study. Even though the average change in body weight was >2kg, no significant changes in intrahepatic lipid (IHL) content could be observed. Total fat mass and total fat-free mass derived from MRI has a strong correlation with the corresponding values derived from BIA and ADP data. BMI and the absolute fat parameter of all three modalities decreased, but there were no or only minor changes regarding the fat-free parameter. Magnetic resonance imaging provides body composition information on abdominal fat distribution changes during a ketogenic diet. This information is complementary to anthropomorphic and laboratory measures and is more detailed than the information provided by ADP and BIA measures. It was shown that there was no significant change in internal fat distribution, but there was a decrease in subcutaneous fat.

Identifiants

pubmed: 31963475
pii: nu12010244
doi: 10.3390/nu12010244
pmc: PMC7019649
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : BE 5760/1-1
Organisme : Helmholtz Association
ID : Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases

Références

J Appl Physiol (1985). 2001 Apr;90(4):1523-31
pubmed: 11247955
J Magn Reson Imaging. 2015 Sep;42(3):811-7
pubmed: 25620624
Diabetes Care. 2009 Jun;32(6):1068-75
pubmed: 19244087
J Magn Reson Imaging. 1997 Nov-Dec;7(6):1002-15
pubmed: 9400843
Magn Reson Med. 2010 Jan;63(1):79-90
pubmed: 19859956
Metabolism. 2002 Jul;51(7):864-70
pubmed: 12077732
Diabetes. 2000 Jun;49(6):883-8
pubmed: 10866038
Magn Reson Med. 1993 Dec;30(6):672-9
pubmed: 8139448
Am J Clin Nutr. 2008 May;87(5):1212-8
pubmed: 18469241
Eur J Nutr. 2013 Mar;52(2):527-35
pubmed: 22543623
Am J Clin Nutr. 2002 Mar;75(3):453-67
pubmed: 11864850
J Magn Reson Imaging. 2007 Mar;25(3):660-5
pubmed: 17326078
Eur J Clin Nutr. 2013 Aug;67(8):789-96
pubmed: 23801097
JAMA. 2003 Jan 1;289(1):76-9
pubmed: 12503980
Diabet Med. 2005 Mar;22(3):266-72
pubmed: 15717873
MAGMA. 2012 Oct;25(5):381-9
pubmed: 22441585
Am J Clin Nutr. 2006 Feb;83(2):260-74
pubmed: 16469983
J Magn Reson Imaging. 2015 Nov;42(5):1214-22
pubmed: 25881207
Eur J Clin Nutr. 2010 Jan;64(1):16-22
pubmed: 19654593
J Biomech. 1996 Sep;29(9):1223-30
pubmed: 8872282
Int J Obes Relat Metab Disord. 1994 Feb;18(2):79-83
pubmed: 8148928
Magn Reson Med. 2018 Jan;79(1):449-458
pubmed: 28432747
Pediatrics. 2007 Mar;119(3):535-43
pubmed: 17332207
Acta Med Scand Suppl. 1988;723:199-203
pubmed: 3164968
Nutrients. 2014 Jun 27;6(7):2493-508
pubmed: 24979615
Am J Clin Nutr. 1996 Sep;64(3 Suppl):397S-404S
pubmed: 8780355
Metabolism. 1983 Aug;32(8):769-76
pubmed: 6865776
Clin Nutr. 2004 Dec;23(6):1430-53
pubmed: 15556267
Clin Sci (Lond). 2008 Apr;114(8):547-52
pubmed: 17990983
J Clin Endocrinol Metab. 2011 Apr;96(4):E691-5
pubmed: 21252252
Nutrients. 2015 Nov 05;7(11):9127-38
pubmed: 26556368
Radiology. 1984 Oct;153(1):189-94
pubmed: 6089263
Prostaglandins Leukot Essent Fatty Acids. 2004 Mar;70(3):309-19
pubmed: 14769489
Am J Physiol Endocrinol Metab. 2001 May;280(5):E745-51
pubmed: 11287357
Am J Clin Nutr. 2016 Aug;104(2):324-33
pubmed: 27385608
Nutr Metab (Lond). 2016 Nov 4;13:77
pubmed: 27822291
J Magn Reson Imaging. 2014 Dec;40(6):1437-44
pubmed: 24449401
Clin Nutr. 2004 Oct;23(5):1226-43
pubmed: 15380917
J Int Soc Sports Nutr. 2012 Jul 26;9(1):34
pubmed: 22835211
Int J Obes Relat Metab Disord. 2003 Dec;27 Suppl 3:S46-8
pubmed: 14704744
Diabetes Care. 2004 Nov;27(11):2726-9
pubmed: 15505012
Nutr Clin Pract. 2004 Oct;19(5):433-46
pubmed: 16215137
World J Gastroenterol. 2019 Mar 7;25(9):1116-1131
pubmed: 30862999
Br J Radiol. 2009 Feb;82(974):123-30
pubmed: 19168691
J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56
pubmed: 15181022
Med Sci Sports Exerc. 1995 Dec;27(12):1686-91
pubmed: 8614326
Nutr Metab (Lond). 2017 Feb 20;14:17
pubmed: 28239404
NMR Biomed. 2011 Aug;24(7):784-90
pubmed: 21834002

Auteurs

Martin Buechert (M)

Department of Radiology, Medical Physics, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Thomas Lange (T)

Department of Radiology, Medical Physics, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Peter Deibert (P)

Institute for Exercise-und Occupational Medicine, Center for Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Paul Urbain (P)

Department of Medicine I, Section of Clinical Nutrition and Dietetics, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH